Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rephalgin N
- Development stage
- Unknown
- Lead developer
- Repha
- Administration
- Oral
01
Overview
**Rephalgin N** is an oral homeopathic medicinal product from Repha for headaches. Each tablet contains homeopathic triturations of *Iris versicolor* D4, *Gelsemium* D4, *Sanguinaria* D6, and *Spigelia* D4. The official product information identifies it as a homeopathic medicine for pain and states that its indication is derived from homeopathic medicinal pictures; no conventional molecular target or pharmacological mechanism of action is specified. ([repha.de](https://www.repha.de/fileadmin/assets_docs/gi/gif-rephalgin-n.pdf))
- Brand names
- Rephalgin N
Beyond the preview
Go deeper on Rephalgin N.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rephalgin N.